Ciclofilin Pharmaceuticals to Present HBV/HIV/HCV Co-Infection Results at EASL 2015
February 17, 2015 09:02 ET
|
Ciclofilin Pharmaceuticals Inc.
SAN DIEGO, Feb. 17, 2015 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals, Inc. ("Ciclofilin" or the "Company"), a biotechnology company focused on the development of broad spectrum antivirals, today...
The Government of Canada Provides Support to Ciclofilin Pharmaceuticals for the Pre-Clinical Development of Its Lead Drug
November 13, 2014 11:38 ET
|
Ciclofilin Pharmaceuticals Inc.
EDMONTON, Alberta, Nov. 13, 2014 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. ("Ciclofilin" or the "Company"), a developer of broad spectrum antiviral medications, announced today that the...
Ciclofilin Pharmaceuticals to Present HIV/HCV Co-Infection Results at AASLD in Boston on November 11
November 04, 2014 07:45 ET
|
Ciclofilin Pharmaceuticals Inc.
SAN DIEGO, Nov. 4, 2014 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals, Inc. ("Ciclofilin" or the "Company"), a biotechnology company focused on the development of broad spectrum antivirals, today...
Ciclofilin Pharmaceuticals Appoints Michael Kamdar to its Board of Directors
October 30, 2014 07:00 ET
|
Ciclofilin Pharmaceuticals Inc.
SAN DIEGO, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. ("Ciclofilin" or the "Company"), a developer of broad spectrum antiviral medications, announced today the appointment of...
Ciclofilin Pharmaceuticals Appoints Stephen F. Keane as Senior VP of Corporate Development
October 27, 2014 11:00 ET
|
Ciclofilin Pharmaceuticals Inc.
SAN DIEGO, Oct. 27, 2014 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. ("Ciclofilin" or the "Company"), a developer of broad spectrum antiviral medications, announced today the appointment of...